Find the right doctor.Get information about our new institute structure.my health. MyChart.Find the right doctor.

Stephen Ellis, M.D.

Print this Content
Email this Content
Appointed: 1991
Gender: Male
Languages: English
Cardiovascular Medicine
Phone:(216) 445-6712
Location:Cleveland Clinic Main Campus
Mail Code J2-3
9500 Euclid Avenue
Cleveland, OH 44195
 
 
Biographical Sketch

Stephen G. Ellis, MD, is the Section Head of Invasive/Interventional Cardiology in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at the Sydell and Arnold Miller Family Heart & Vascular Institute. He also is co-director and co-founder of the Cardiovascular Genebank. His principal clinical interests are complex coronary interventions, novel treatments for inoperable patients and studies to better understand the basis of disease.

Board-certified in internal medicine cardiology and interventional cardiology, Dr. Ellis is a member of the American Heart Association's Scientific Council on Arteriosclerosis and Scientific Council on Clinical Cardiology, the Society for Cardiac Angiography and Interventions and the American College of Cardiology.

He also serves on the editorial boards for numerous publications, including the American Journal of Cardiology, the Journal of Interventional Cardiology, Circulation and the American Heart Journal. Dr. Ellis has authored and co-authored more than 700 papers on interventional cardiology and cardiovascular disease for scientific journals including the New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and American Journal of Cardiology.

He has also served as the principal investigator for numerous national and international clinical studies that focus on intervention, including the RESCUE I trial, GUSTO IIb PTCA study, ERASER study, the GUARD trial, TAXUS IV and V trials and the FINESSE trial.

A graduate of the University of California (at Los Angeles) Medical School, Dr. Ellis completed his internship and residency at Cedars-Sinai Medical Center in Los Angeles and his fellowships at the Brigham and Women's Hospital (Cardiology) in Boston, Stanford University (Cardiology) in Stanford, Calif., and Emory University (Angioplasty) in Atlanta.

He has also served as the principal investigator for numerous clinical studies that focus on intervention, including the RESCUE I trial, GUSTO IIb PTCA study, ERASER study, the GUARD trial, TAXUS IV and V trials and the FINESSE trial.

A graduate of the University of California (at Los Angeles) Medical School, Dr. Ellis completed his internship and residency at Cedars-Sinai Medical Center in Los Angeles and his fellowships at the Brigham and Women's Hospital (Cardiology) in Boston, Stanford University (Cardiology) in Stanford, Calif., and Emory University (Angioplasty) in Atlanta.

Back to Top
Education & Fellowships
Medical School:University of California-Los Angeles School of Medicine, Los Angeles, CA
 
Internship:Cedars-Sinai Medical Center, Internal Medicine, Los Angeles, CA
Residency:Cedars-Sinai Medical Center, Internal Medicine, Los Angeles, CA
Fellowship:Emory University Hospital, Angioplasty, Decatur, GA
Fellowship:Stanford University Hospital, Cardiology, Stanford, CA
Fellowship:Brigham & Women's Hospital, Cardiology, Boston, MA
Other Education:(Undergraduate) Stanford University, Palo Alto, CA
Back to Top
Additional Training
  • Molecular Biology, Penn State University
Back to Top
Certifications

Interventional Cardiology

Cardiovascular Disease

Internal Medicine

Back to Top
Specialty Interests
Stenting, therapeutic angiogenesis and other novel forms of coronary revascularization, genetic abnormalities predisposing to coronary atherosclerosis, percutaneous valve repair.
Back to Top
Awards & Honors
  • Regent’s Scholar, University of California, 1973-1976, 1978
  • Distinguished Teaching Awards, 1992, 1996, 2003
  • The Best doctors in America, Cleveland Clinic,  1993-present
  • The Best Doctors in Cleveland, 2001-present
  • NIH funding in acute myocardial infarction, genomics and stem cell research, 2002-present
Back to Top
Professional Memberships
  • American College of Cardiology, 1985-Present
  • American College of Physicians, 1980-Present
  • American Association for Advancement of Science,1992-Present
  • American Heart Association, Scientific Council on Arteriosclerosis,1995-Present
  • American Heart Association, Scientific Council on Clinical Cardiology,1995-Present
Back to Top
Specializes in Diseases and Conditions
Back to Top
Specializes in Services
Back to Top
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Ellis has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Ellis receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
  • Abbott Vascular
  • BioHeart Inc.
  • Boston Scientific Corporation
  • Cordis Corporation
  • Viacor, Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)